Human papillomavirus type 16 early proteins E1, E2, E4, and E5 (HPV-16 E1/E2/E4/E5)

The HPV-16 E1, E2, E4, and E5 proteins are a group of early-stage viral proteins essential for the life cycle and pathogenesis of Human Papillomavirus type 16, the primary causative agent of cervical cancer [1, 6, 13]. E1 functions as an ATP-dependent DNA helicase that, together with the E2 transcription factor, initiates viral DNA replication at the origin [9, 15, 25]. E2 also serves as a critical regulator of viral gene expression, typically repressing the oncogenic E6 and E7 proteins in the episomal state; its loss during viral integration is a key step in malignant transformation [8, 14, 22]. The E4 protein (often expressed as the E1^E4 fusion) facilitates viral release by disrupting the host cell's keratin cytoskeleton and inducing G2 cell cycle arrest [10, 11, 20]. E5 is a small transmembrane oncoprotein that enhances growth factor signaling (e.g., EGFR) and promotes immune evasion by downregulating MHC class I molecules [1, 3, 4, 7]. These proteins are significant therapeutic targets for the development of antiviral small molecules, such as E1-E2 interaction inhibitors, and therapeutic vaccines like MVA-E2 designed to eliminate persistent infections and prevent progression to malignancy [16, 23, 27, 29].

Other names

HPV16 E1/E2/E4/E5Human papillomavirus 16 early proteinsHPV-16 E1, E2, E4, E5 proteinsHPV-16 early gene products

Inhibition of viral DNA replication by disrupting E1-E2 interaction; induction of T-cell mediated immune response against early viral antigens; restoration of E2-mediated transcriptional repression of E6 and E7 oncoproteins.